Katherine A.D. Krueger

Partner, Patent Attorney

Kate is a partner at VHPM and a registered US Patent Attorney. Kate specializes in helping clients in the biological and biochemical arts fields, evaluating, developing and managing global patent portfolios, as well as performing opinion work. She assists clients with inventions related to molecular biology, cellular biology, immunology, gene therapy, RNA inhibition and diagnostics. When she’s not at work, Kate and her husband are busy raising two daughters. When she does get a moment to herself, Kate enjoys reading.

Kate's Most Recent Book: Anthony Doerr’s All the Light We Cannot See.

University of Minnesota Law School, J.D., cum laude, 2009

University of Minnesota, Ph.D., Molecular, Cellular, Developmental Biology & Genetics, 2008

Saint Olaf College, B.A., cum laude, double major in Biology and Economics, 2000

“After the Deal Is Done”, AUTM Central Regional Meeting (July 2016) and Eastern Regional Meeting (September 2016).

Jeremy McKown and Katherine Krueger, “Compulsory Licensing and the Impact of Bayer Corporation v. Union of India”, AIPLA Spring Meeting paper (May 2014).

“Association for Molecular Pathology v. Myriad Genetics, Inc.: Isolated DNA is Not Patent Eligible Subject Matter”, LES Minnesota Chapter Meeting, Minneapolis, MN (September 2013).